Section 508 Website Accessibility

Skip to site navigation Skip to main content
Skip to main content
Chief of Staff

Chief of Staff

Office of Vice President and Chief of Staff
News and Media
Related Links

Office of Vice President and
Chief of Staff
Florida Gulf Coast University
10501 FGCU Blvd S.
Fort Myers, FL. 33965-6565

Phone: (239) 590-1006
Fax:     (239) 590-1066

Press Release


FGCU Hosts Public Seminar Tuesday to Discuss the Effect of Host Cell Functions on Retroviral DNA Integration

FORT MYERS, FL - The Florida Gulf Coast University Biotechnology Seminar Series invites members of the public, healthcare community and media to "Effect of Host Cell Functions on Retroviral DNA Integration" 9:30 a.m., Tuesday, Oct. 4 in Whitaker Hall 268.

The free seminar features speaker Anna Marie Skalka, director of the Institute for Cancer Research and senior vice president of the Fox Chase Cancer Center in Philadelphia.

Skalka studies the molecular aspects of retroviral replication and has made significant contributions to elucidating the mechanism of retroviral DNA integration, which allows the virus to establish a long-term infection in the host.

A better understanding of the molecular aspects of retroviral DNA integration provides the basis for the development of novel antiviral drugs to treat AIDS.

Skalka received an A.B. degree in biology from Adelphi University and a Ph.D. in microbiology/biochemistry from New York University. She holds adjunct appointments in the Department of Molecular Genetics at the Albert Einstein College of Medicine and the Department of Microbiology at the University of Pennsylvania.

She has held positions at the Roche Institute of Molecular Biology and Hoffman-La Roche, Inc. prior to her appointment at the Fox Chase Cancer Center.

Skalka is currently on the editorial board of premier journals in her field including the Journal of Virology, Cancer Research, and the Journal of Biological Chemistry.

For more information, contact assistant professor of biotechnology Sharon Isern at (239) 590-7438 or

[Back to the Press Release Archives]